Daniel S. Harrison, MD
Assistant Professor of Neurology

- Title Assistant Professor of Neurology
- Education Medical School: Duke University School of Medicine, Durham, NC
Internship: Internal medicine, Brigham and Women’s Hospital, Boston, MA
Residency: Neurology, Mass General Brigham, Boston, MA
Fellowship: Neurocritical Care Fellowship, Mass General Brigham, Boston, MA
Dr. Daniel Harrison is a neurointensivist at Boston Medical Center and Assistant Professor of Neurology at Boston University School of Medicine. Dr. Harrison’s research focuses on neurology training for advanced practice providers and medical simulation for neurology learners. Dr. Harrison’s research and education work has been recognized both locally and internationally. His description of neurologic education in physician assistant programs was named among the “News That Mattered in 2022” by Neurology Today. He was named neurology fellow educator of the year and simulation educator of the year at Brigham and Women’s Hospital in 2024. He has led several multi-center educational research collaborations. Dr. Harrison received his medical degree from Duke University School of Medicine, where he was elected to the Alpha Omega Alpha Medical Honor society. He completed residency in neurology and fellowship in neurocritical care at Mass General Brigham, where he served as chief resident.
Recent Publications
Harrison DS. Hickam’s Dictum: A Case of Intracerebral Hemorrhage with Multiple Contributing Risk Factors. Neurocrit Care. 2024 Feb;40(1):367-370. doi: 10.1007/s12028-023-01904-0. Epub 2024 Jan 2. PMID: 38167963.
Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R. COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. 2022 Mar;269(3):1093-1106. doi: 10.1007/s00415-021-10780-7. Epub 2021 Sep 4. PMID: 34480607; PMCID: PMC8417681.
Harrison D, Mehta P, van Es MA, Stommel E, Drory VE, Nefussy B, van den Berg LH, Crayle J, Bedlack R; Pooled Resource Open-Access ALS Clinical Trials Consortium. “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):495-499. doi: 10.1080/21678421.2018.1457059. Epub 2018 Apr 2. PMID: 29607695.
Li Y, North RY, Rhines LD, Tatsui CE, Rao G, Edwards DD, Cassidy RM, Harrison DS, Johansson CA, Zhang H, Dougherty PM. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain. J Neurosci. 2018 Jan 31;38(5):1124-1136. doi: 10.1523/JNEUROSCI.0899-17.2017. Epub 2017 Dec 18. PMID: 29255002; PMCID: PMC5792474.
Li Y, Tatsui CE, Rhines LD, North RY, Harrison DS, Cassidy RM, Johansson CA, Kosturakis AK, Edwards DD, Zhang H, Dougherty PM. Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy. Pain. 2017 Mar;158(3):417-429. doi: 10.1097/j.pain.0000000000000774. PMID: 27902567; PMCID: PMC5303135.
Li Y, Adamek P, Zhang H, Tatsui CE, Rhines LD, Mrozkova P, Li Q, Kosturakis AK, Cassidy RM, Harrison DS, Cata JP, Sapire K, Zhang H, Kennamer-Chapman RM, Jawad AB, Ghetti A, Yan J, Palecek J, Dougherty PM. The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4. J Neurosci. 2015 Sep 30;35(39):13487-500. doi: 10.1523/JNEUROSCI.1956-15.2015. PMID: 26424893; PMCID: PMC4588613.
Li Y, Zhang H, Kosturakis AK, Cassidy RM, Zhang H, Kennamer-Chapman RM, Jawad AB, Colomand CM, Harrison DS, Dougherty PM. MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy. Brain Behav Immun. 2015 Oct;49:255-66. doi: 10.1016/j.bbi.2015.06.003. Epub 2015 Jun 9. PMID: 26065826; PMCID: PMC4567501.
Wood ET, Ronen I, Techawiboonwong A, Jones CK, Barker PB, Calabresi P, Harrison D, Reich DS. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J Neurosci. 2012 May 9;32(19):6665-9. doi: 10.1523/JNEUROSCI.0044-12.2012. PMID: 22573688; PMCID: PMC3360480.
- Divisions
- Neurocritical Care